Designing of DNA Vaccine Based on a Secretory Form of Major Capsid Protein of Human Papillomavirus Type 18
In conclusion, pVAX1-tPA-PADRE-L1 recombinant plasmid is a highly immunogenic construct and suggests as a promising candidate for vaccine development against HPV type 18 in low-middle-income countries.PMID:34664812 | DOI:10.18502/ijaai.v20i5.7403
Source: Iranian Journal of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Somayeh Shokri Shahab Mahmoudvand Manoochehr Makvandi Reza Taherkhani Mohammad Rashno Farid Azizi Jalilian Kambiz Ahmadi Angali Mohammad Ali Foroughi Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Genetics | Genital Warts | Human Papillomavirus (HPV) | Iran Health | Middle East Health | Study | Vaccines